Cargando…

miR-638 Serves as a Biomarker of 5-Fluorouracil Sensitivity to Neoadjuvant Chemotherapy in Breast Cancer

PURPOSE: Neoadjuvant chemotherapy (NAC) is widely used to treat breast cancer (BC). The prediction and evaluation of chemotherapy responses remains a significant challenge. METHODS: MicroRNAs (miRNAs) play a crucial role in cancer drug resistance. We used a miRNA microarray and identified that miR-6...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Bin, Wang, Kun, Yu, Jian, Hao, Xiao-meng, Liu, Yu-lu, Xing, Ai-Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Breast Cancer Society 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250877/ https://www.ncbi.nlm.nih.gov/pubmed/35775701 http://dx.doi.org/10.4048/jbc.2022.25.e24

Ejemplares similares

miR-638 is a new biomarker for outcome prediction of non-small cell lung cancer patients receiving chemotherapy
por: Wang, Fang, et al.
Publicado: (2015)

MiR-638 Repressed Vascular Smooth Muscle Cell Glycolysis by Targeting LDHA
por: Chen, Shiyuan, et al.
Publicado: (2019)

MiR-638 acts as a tumor suppressor gene in gastric cancer
por: Shen, Yu, et al.
Publicado: (2017)

Circulating miR-326 could serve as a predictive biomarker for response to neoadjuvant chemotherapy in locally advanced cervical cancer
por: Zou, Kangni, et al.
Publicado: (2022)

Dysregulation of miR-638 in diabetic nephropathy and its role in inflammatory response
por: Lin, Mei, et al.
Publicado: (2021)

Aspartate β-Hydroxylase Serves as a Prognostic Biomarker for Neoadjuvant Chemotherapy in Gastric Cancer
por: Gan, Xuejun, et al.
Publicado: (2023)

Downregulation of circulating exosomal miR-638 predicts poor prognosis in colon cancer patients
por: Yan, Shushan, et al.
Publicado: (2017)

miR-638 regulates gene expression networks associated with emphysematous lung destruction
por: Christenson, Stephanie A, et al.
Publicado: (2013)

Exosomal miR-638 Inhibits Hepatocellular Carcinoma Progression by Targeting SP1
por: Yang, Jing, et al.
Publicado: (2020)

Prognostic and clinicopathological significance of miR-638 in cancer patients: A meta-analysis
por: Hu, Lixia, et al.
Publicado: (2021)

Downregulation of miR-638 promotes progression of breast cancer and is associated with prognosis of breast cancer patients
por: Li, Minghong, et al.
Publicado: (2018)

miR-638 promotes melanoma metastasis and protects melanoma cells from apoptosis and autophagy
por: Bhattacharya, Animesh, et al.
Publicado: (2014)

Exosomal miR-638 Inhibits Hepatocellular Carcinoma Progression by Targeting SP1 [Retraction]
Publicado: (2021)

Identification of miRNA Signature in Breast Cancer to Predict Neoadjuvant Chemotherapy Response
por: Xing, Ai-Yan, et al.
Publicado: (2021)

miR-638 mediated regulation of BRCA1affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancer
por: Tan, Xiaohui, et al.
Publicado: (2014)

Methylation-associated silencing of miR-638 promotes endometrial carcinoma progression by targeting MEF2C
por: Ni, Jianjiao, et al.
Publicado: (2020)

miR-638 suppresses proliferation by negatively regulating high mobility group A1 in ovarian cancer cells
por: Ma, Li, et al.
Publicado: (2021)

miR-148a and miR-375 may serve as predictive biomarkers for early diagnosis of laryngeal carcinoma
por: Wu, Ying, et al.
Publicado: (2016)

Serum miR-4530 sensitizes breast cancer to neoadjuvant chemotherapy by suppressing RUNX2
por: Wang, Xiao-Xiao, et al.
Publicado: (2018)

CREB1/Lin28/miR-638/VASP Interactive Network Drives the Development of Breast Cancer
por: Hu, Peng-Chao, et al.
Publicado: (2019)

Secretion of small/microRNAs including miR-638 into extracellular spaces by sphingomyelin phosphodiesterase 3
por: KUBOTA, SHIORI, et al.
Publicado: (2015)

LACTB and LC3 could serve as potential biomarkers of gastric cancer to neoadjuvant chemotherapy with oxaliplatin plus S-1
por: Yang, Fang, et al.
Publicado: (2021)

Effect of Xuezhikang Therapy on Expression of Pulmonary Hypertension Related miR-638 in Patients With Low HDL-C Levels
por: Cao, Ruihua, et al.
Publicado: (2021)

Identification of Four Oxidative Stress-Responsive MicroRNAs, miR-34a-5p, miR-1915-3p, miR-638, and miR-150-3p, in Hepatocellular Carcinoma
por: Wan, Yong, et al.
Publicado: (2017)

Hsa_circ_0001869 promotes NSCLC progression via sponging miR-638 and enhancing FOSL2 expression
por: Xu, Pei, et al.
Publicado: (2020)

Exosome-Encapsulated miR-31, miR-192, and miR-375 Serve as Clinical Biomarkers of Gastric Cancer
por: He, Jing, et al.
Publicado: (2023)

miR-206 as a prognostic and sensitivity biomarker for platinum chemotherapy in epithelial ovarian cancer
por: Yu, Xiaotang, et al.
Publicado: (2020)

Microsatellite instability states serve as predictive biomarkers for tumors chemotherapy sensitivity
por: Ye, Taojun, et al.
Publicado: (2023)

miR-638 suppresses DNA damage repair by targeting SMC1A expression in terminally differentiated cells
por: He, Mingyang, et al.
Publicado: (2016)

Hsa_circ_0043278 functions as competitive endogenous RNA to enhance glioblastoma multiforme progression by sponging miR-638
por: Wu, Zhi, et al.
Publicado: (2020)

Neoadjuvant Chemotherapy with Fluorouracil plus Nedaplatin or Cisplatin for Locally Advanced Nasopharyngeal Carcinoma: a Retrospective Study
por: Liu, Tongxin, et al.
Publicado: (2018)

NEAT1 knockdown suppresses endothelial cell proliferation and induces apoptosis by regulating miR-638/AKT/mTOR signaling in atherosclerosis
por: Zhang, Xia, et al.
Publicado: (2020)

Assessment of neoadjuvant chemotherapy with docetaxel, cisplatin, and fluorouracil in patients with oral cavity cancer
por: Fu, Jin Ye, et al.
Publicado: (2022)

Serum miR-214 Serves as a Biomarker for Prodromal Parkinson’s Disease
por: Li, Lanting, et al.
Publicado: (2021)

Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF
por: Cheng, Jiwen, et al.
Publicado: (2016)

Current clinical practice and outcome of neoadjuvant chemotherapy for early breast cancer: analysis of individual data from 94,638 patients treated in 55 breast cancer centers
por: Ortmann, O., et al.
Publicado: (2022)

Circulating miR-21 serves as a serum biomarker for hepatocellular carcinoma and correlated with distant metastasis
por: Guo, Xin, et al.
Publicado: (2017)

Serum exosomal miR‐638 is a prognostic marker of HCC via downregulation of VE‐cadherin and ZO‐1 of endothelial cells
por: Yokota, Yuki, et al.
Publicado: (2021)

Is there a correlation between miR-301a expression and neoadjuvant chemotherapy efficacy in breast cancer tissue?
por: Deng, Shanshan, et al.
Publicado: (2021)

Loss of miR-638 in vitro promotes cell invasion and a mesenchymal-like transition by influencing SOX2 expression in colorectal carcinoma cells
por: Ma, Kelong, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rmumelvijq7st1lttqkfj2dbmg